ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Syros Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Syros Pharmaceuticals, INC. (Syros Pharmaceuticals, INC. 401(k) Plan · EIN 45-3772460 · PN 001): $6.14M net assets, 4 active participants, and $46.61 per $10,000 (46.61 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorSyros Pharmaceuticals, INC.
Filing IdentifierSyros Pharmaceuticals, INC. 401(k) Plan · EIN 45-3772460 · PN 001
Plan Category & State401(k) Defined Contribution (AZ)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$6.14M
Active Participants4
Direct Admin Fee Rate$46.61 per $10,000 (46.61 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderHUB / Global Retirement Partners
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI